Clinical trials
Completed Myasthenia Gravis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| UCB Biopharma SRL | 4 |
| argenx | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Grifols Therapeutics LLC | 2 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| Hoffmann-La Roche | 1 |
| Institut de Myologie, France | 1 |
| Poitiers University Hospital | 1 |
| Ra Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 21 |
| COVID-19 | 1 |
| Guillain-Barre Syndrome | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Myasthenic Syndromes, Congenital | 1 |
| Myositis | 1 |
| Neuromuscular Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.